Craneware plc Share Purchase by Chairman Designate (6569T)
18 Novembre 2019 - 8:00AM
UK Regulatory
TIDMCRW
RNS Number : 6569T
Craneware plc
18 November 2019
Craneware plc
("Craneware" or the "Company")
Purchase of Ordinary Shares by Chairman Designate
18 November 2019 - Craneware plc (AIM: CRW.L), the market leader
in Value Cycle software solutions for the US healthcare market, has
been informed that on 14 November 2019 incoming Chairman, Will
Whitehorn, purchased 1,171 ordinary shares of 1p each in the
Company ('Ordinary Shares') at a price of 2,550p per share.
Following this purchase, Mr. Whitehorn holds 1,171 Ordinary
Shares in the Company, representing 0.004 per cent. of the
Company's issued share capital.
Appendix:
PDMR notification: William Whitehorn
1. Details of the Restricted Person / person closely associated with
him or her
a) Name William Whitehorn
2. Reason for the notification
a) Position / status Incoming Chairman
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been conducted
a) Description of the financial Ordinary shares of 1p each in the
instrument, type of instrument capital of Craneware plc "Ordinary
Shares"
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Purchase of Ordinary Shares
d) Price(s) and volume(s) Volume(s) 1,171, Price(s) GBP25.50
e) Aggregated information:
i. Aggregated volume Aggregate volume(s) 1,171
ii. Price Price(s) GBP25.50
f) Date of the transaction 2019-11-14
g) Place of the transaction London Stock Exchange (XLON)
For further information, please contact:
Craneware plc Peel Hunt (NOMAD & Joint Investec Bank (Joint Alma (Financial
Broker) Broker) PR)
+44 (0)131 550 +44 (0)203 405
3100 +44 (0)20 7418 8900 +44 (0)20 7597 5970 0205
Keith Neilson, Dan Webster Patrick Robb Caroline Forde
CEO
Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan
CFO
Guy Pengelley Henry Reast Helena Bogle
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated Value Cycle solutions that
help US Healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware is headquartered in
Edinburgh, Scotland with offices in Atlanta and Pittsburgh
employing over 350 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEADFKFSKNFFF
(END) Dow Jones Newswires
November 18, 2019 02:00 ET (07:00 GMT)
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024